文献速递生殖医学

不孕子宫内膜异位症患者IVF结局的队列研究:雷帕霉素治疗的影响

A cohort study on IVF outcomes in infertile endometriosis patients: the effects of rapamycin treatment.
PubMed 文献 · Reprod Biomed Online · 2023-07-29

这项回顾性分析纳入168例子宫内膜异位症患者,均接受两个连续IVF周期。治疗组(n=80)在第二周期前接受3个月雷帕霉素,非治疗组(n=88)无辅助治疗。结果显示治疗组氧化应激和衰老标志物降低,IVF结局改善,但结论需前瞻性随机对照试验进一步验证。

要点

  • 雷帕霉素组第二周期卵泡液中氧化应激标志物降低、抗氧化标志物升高(均P<0.001)。
  • 雷帕霉素组衰老标志物p16和p21表达显著低于非治疗组(P<0.001)。
  • 雷帕霉素组第二周期促排卵天数更少,获卵数和成熟卵数更多,受精率、着床率、临床妊娠率和活产率更高。

核心结论

  • 本研究提示短期雷帕霉素治疗与改善IVF妊娠结局存在关联,该结果需在前瞻性随机对照临床试验中进一步研究。

研究设计与样本

  • 回顾性分析纳入168例子宫内膜异位症患者,均接受两个连续IVF周期;治疗组(n=80)在第二IVF周期前接受3个月雷帕霉素,非治疗组(n=88)无辅助治疗。
  • 比较组间及组内第一和第二IVF周期;检测两周期卵泡液(治疗组n=28,非治疗组n=32)中衰老相关和氧化应激相关标志物。

主要发现

  • 第二周期卵泡液比较:雷帕霉素治疗组氧化应激标志物8-羟基脱氧鸟苷和丙二醛降低,抗氧化标志物超氧化物歧化酶和谷胱甘肽过氧化物酶升高(均P<0.001)。
  • 第二周期卵泡液比较:治疗组衰老相关标志物p16和p21表达显著低于非治疗组(P<0.001)。
  • 第二周期IVF比较:治疗组促排卵天数更少,获卵数和成熟卵数更多(均P<0.001)。
  • 第二周期IVF比较:治疗组受精率、着床率和临床妊娠率显著更高(P=0.008、0.034和0.038),活产率也更高(P=0.003)。
  • 雷帕霉素治疗女性所生胎儿未见结构异常。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Can rapamycin, used as an anti-senescence drug before IVF cycles, improve the IVF outcomes of women with endometriosis by reducing oxidative stress and senescence? DESIGN: This retrospective analysis involved 168 endometriosis patients undergoing two successive IVF cycles. The treatment group (n = 80) received 3 months of rapamycin before the second IVF cycle, while the non-treatment group (n = 88) had no adjuvant treatment. The first and second IVF cycles were compared between and within groups. Follicular fluid from both IVF cycles (treatment group n = 28, non-treatment group n = 32) were tested for senescence-associated and oxidative stress-related markers. RESULTS: Comparing the follicular fluid from the second cycles, the rapamycin treatment group showed decreased markers of oxidative stress (8-hydroxydesoxyguanosine, malondialdehyde) and increased antioxidant markers (superoxidase dismutase, glutathione peroxidase) (all P < 0.001); the expression of senescence-related markers p16 and p21 was also significantly lower in the treatment group than in the non-treatment group (P < 0.001). Comparing the second IVF cycles, the treatment group needed fewer days of ovarian stimulation, with increased numbers of oocytes obtained and mature oocytes compared with the non-treatment group (all P < 0.001). Furthermore, rates of fertilization, implantation and clinical pregnancy were significantly higher in the treatment group (P = 0.008, 0.034 and 0.038 respectively), as was the live birth rate (P = 0.003). No structural abnormalities were seen in fetuses born to women treated with rapamycin. CONCLUSIONS: This study suggested an association between short-term rapamycin treatment and improved pregnancy outcomes via IVF. This result needs to be further investigated in prospective randomized controlled clinical trials.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Fan J, Chen C, Zhong Y, et al. A cohort study on IVF outcomes in infertile endometriosis patients: the effects of rapamycin treatment. Reprod Biomed Online. 2023. PMID: 37914557. doi:10.1016/j.rbmo.2023.103319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。